pegtarviliase (AGLE-177) / Spyre Therap  >>  Phase 2
Welcome,         Profile    Billing    Logout  

1 Trials

Remove FilterRemove Filter

 
Trial + Data / EventsStatusPhNRegionInterventionsSponsorConditionsPrimary complStudy compl
pegtarviliase (AGLE-177) / Aeglea
CACN00177-100D, NCT05154890: A Multiple Ascending Dose Study of ACN00177 (Pegtarviliase) in Subjects With CBS Deficiency

Terminated
1/2
13
Europe, US, RoW
Pegtarviliase IV, ACN00177, Pegtarviliase SC
Aeglea Biotherapeutics
Homocystinuria Due to Cystathionine Beta-Synthase Deficiency
04/23
04/23

Download Options